glp-1 vs glp 2 vs glp 3 Retatrutide Semaglutide and Tirzepatide: GLP-3 Facts explained Emerging Frontiers in GLP-1 Therapeutics:

Step 3: The Bait-and-Switch Near the end of the video, the narrator claims the original recipe is too hard to follow or not optimized

Anti-estrogen therapies such as tamoxifen can also reduce risk substantially, yet uptake has historically been low because of concerns about side effects

For semaglutide specifically, treatment should be discontinued at least 2 months before a planned pregnancy

In this podcast episode,

Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively